反击

CVS removing decongestant from shelves after FDA panel says it's ineffective_我的网站

出租车司机

一 | CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。今年三季度，省市场监管局共发布辽宁省地方标准47项，涉及领域同比增加12个。1月至9月，我省共新增地方标准139项，累计已达2096项。　　从发布的地方标准领域看，现代农业18项、水产养殖5项、抗旱保障1项、通信技术3项、信息安全3项、交通运输5项、市场监管2项。　　在现代农业方面，《玉米大豆轮作耕地保育技术规范》对实现土地用养结合、作物持续丰产增效、增加农业效益和提高农民收入具有重要指导作用，对深化我省农业供给侧结构性改革，保障粮食安全和生态安全具有积极意义。　　在循环经济方面，《建筑垃圾资源化利用技术规程》能够有效衔接国家关于建筑垃圾减量化与资源化利用的政策要求，能够有效突破我省建筑垃圾资源化产业技术瓶颈，增强市场竞争力，推动循环经济发展。　　在清洁能源方面，《太阳能光伏光热热泵系统技术规程》有利于推广清洁能源供能系统的工程化应用，对于实现安全适配、降本增效具有重要作用，将有效推动我省太阳能建筑一体化技术发展。　　在建筑科技方面，《碳纤维增强聚合物-钢管混凝土柱技术规程》符合国家“城市更新”“碳达峰、碳中和”发展战略，相关科研成果为我省自有知识产权，可为高耐久性建筑的设计、施工及验收提供技术支撑，确保工程质量，对提高建筑耐久性具有重要作用。　　在矿山建设方面，《超大规模超深井智慧矿山建设规范》将为我省超大规模超深井矿山企业创新管理、变革发展提供标准化技术方案，填补了国内该领域标准空白，将推动高效、节约、安全、环保的智慧矿山建设，产生显著的社会和经济效益。